Oramed to Present at Three Upcoming Conferences
NEW YORK, Sept. 3, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the company will present at three conferences in New York in the first half of September 2019. RHK Capital 4th Annual Disruptive Growth ConferenceDate: September 4, […]
